Back to cases

Neurology · Autism (ASD)

张*· 6

Country
China
Treatment start
2021-10-15

Anamnesis

Zhāng*, age 6, 26 kg. After age 2, parents noticed limited speech. After starting school, teachers reported Zhāng did not interact or play with other children. Medical examination revealed elevated neuron-specific enolase (NSE 24.08 ng/mL). At age 6, still cannot communicate normally, only imitates others' speech.

Treatment plan

2021-10-15 — intravenous placental mesenchymal stem cells (P-MSC) 2U, once monthly, 3 administrations = 1 cycle.

SchemaPlacental MSC 2U IV monthly × 3
Therapy
P-MSC (placental MSC)
Delivery route
Intravenous (IV)

Outcome

Speech clearer, reactions faster, movements more coordinated, mental state energetic. Bowel and urinary function normal, voice clear, comprehends questions, comprehension and cognitive skills improved. Improvements in sleep, appetite, and skin.

Background

Pediatric autism is a developmental mental disorder of early childhood. Core features: impaired social interaction, communication impairment, restricted interests and activities, stereotyped repetitive behavior. Most children show varying degrees of mental developmental delay.

Physician conclusion

No adverse reactions observed. Stem cell transplantation for pediatric autism effectively alleviates associated symptoms.

Discuss your case

Share your diagnosis and history — the academic board responds within 24 hours with a preliminary assessment and protocol outline.

Get a consultation

We use cookies and analytics services to improve the website experience. Privacy Policy